Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Ryusei, Saito"'
Autor:
Mototsugu Shimokawa, Masaki Kanazu, Ryusei Saito, Masahide Mori, Atsuhisa Tamura, Yoshio Okano, Yuka Fujita, Takeo Endo, Mitsuru Motegi, Shohei Takata, Toshiyuki Kita, Noriaki Sukoh, Fumitaka Mizuki, Mitsuhiro Takenoyama, Shinji Atagi
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1597-1605 (2023)
Abstract Background Previous trials suggest that older adults with non‐small cell lung cancer (NSCLC) derive benefit from platinum doublet combination therapy, but its superiority is controversial. Although geriatric assessment variables are used t
Externí odkaz:
https://doaj.org/article/76404a9fd6d2454e84c0f25fef6834a6
Autor:
Reiko Sakurai, Kyoichi Kaira, Yosuke Miura, Noriaki Sunaga, Ryusei Saito, Tetsunari Oyama, Takeshi Hisada, Masanobu Yamada
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 426-435 (2020)
Abstract Background Amrubicin chemotherapy is a treatment option for patients with non‐small cell lung cancer (NSCLC) after third‐line treatment in Japan. Although topoisomerase‐II (Topo‐II), a target of amrubicin, has been reported to be a p
Externí odkaz:
https://doaj.org/article/c0b4fba13a874cfb9b70046a0f81224f
Autor:
Jun‐ichi Saitoh, Katsuyuki Shirai, Tatsuji Mizukami, Takanori Abe, Takeshi Ebara, Tatsuya Ohno, Koichi Minato, Ryusei Saito, Masanobu Yamada, Takashi Nakano
Publikováno v:
Cancer Medicine, Vol 8, Iss 15, Pp 6644-6650 (2019)
Abstract This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically prove
Externí odkaz:
https://doaj.org/article/924d223372a14635a8b6b020f659285d
Autor:
Nobuhiro Akuzawa, Makoto Kurabayashi, Tsukasa Suzuki, Daisuke Yoshinari, Mitsunobu Kobayashi, Yoshifumi Tanahashi, Fujio Makita, Ryusei Saito
Publikováno v:
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-6 (2017)
Abstract Background Spontaneous isolated dissection of the superior mesenteric artery (SMA) can lead to bowel ischemia, aneurysm rupture, or even death. Studies have suggested that mechanical or hemodynamic stress on the vascular wall of the SMA may
Externí odkaz:
https://doaj.org/article/4b7ce85312894b8fbe765fa7bd17ad9b
Autor:
Masaki Kanazu, Mototsugu Shimokawa, Ryusei Saito, Masahide Mori, Atsuhisa Tamura, Yoshio Okano, Yuka Fujita, Takeo Endo, Mitsuru Motegi, Shohei Takata, Toshiyuki Kita, Noriaki Sukoh, Mitsuhiro Takenoyama, Shinji Atagi
Publikováno v:
Journal of geriatric oncology. 13(8)
Previous studies have developed risk stratification schemas to assess systemic therapy toxicity. However, it is controversial which geriatric assessment variables should be used to assess the individual risk of severe treatment-associated toxicity in
Autor:
Yosuke Miura, Tetsunari Oyama, Kyoichi Kaira, Reiko Sakurai, Masanobu Yamada, Ryusei Saito, Takeshi Hisada, Noriaki Sunaga
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 426-435 (2020)
Thoracic Cancer
Thoracic Cancer
Background Amrubicin chemotherapy is a treatment option for patients with non-small cell lung cancer (NSCLC) after third-line treatment in Japan. Although topoisomerase-II (Topo-II), a target of amrubicin, has been reported to be a prognostic or pred
Autor:
Koichi Minato, Takeshi Ebara, Masanobu Yamada, Takashi Nakano, Katsuyuki Shirai, Ryusei Saito, Jun-ichi Saitoh, Tatsuya Ohno, Takanori Abe, Tatsuji Mizukami
Publikováno v:
Cancer Medicine, Vol 8, Iss 15, Pp 6644-6650 (2019)
Cancer Medicine
Cancer Medicine
This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically proven periphe
Autor:
Nobuhiro Akuzawa, Akihiro Ono, Asuka Jingu, Ryusei Saito, Takashi Osaki, Tomohito Kuwako, Sho Osawa, Akihiro Yoshii, Satoru Watanabe
Publikováno v:
Alzheimer Disease and Associated Disorders
Background Difficulty with oral feeding, the most commonly observed complication of Alzheimer disease (AD) in its final stages, occurs in 86% of AD patients and may prevent achievement of oral feeding after aspiration pneumonia. However, no reliable
Autor:
Mitsuyoshi Utsugi, Reiko Sakurai, Noriaki Sunaga, Akira Mogi, Yoshio Tomizawa, Tomohito Kuwako, Tomomi Masuda, T. Ishizuka, Kyoichi Kaira, Atsushi Takise, Yosuke Miura, Ryusei Saito, Kimihiro Shimizu, Kaori Seki, Koichi Minato, Masanobu Yamada, Hisao Imai, Shinichi Ishihara, Takeshi Hisada
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose In patients with epidermal growth factor receptor (EGFR)-mutated, advanced, non-small cell lung cancer (NSCLC), common gefitinib-sensitive EGFR mutations that predict a greater response to therapy include the exon 19 deletion and L858R point
Autor:
Hiroki Tanikawa, Ryusei Saito, Chizuko Hirai, Hiroaki Shirakawa, Chihiro Haga, Takanori Matsui
Publikováno v:
Journal of Japan Society of Civil Engineers, Ser. G (Environmental Research). 76:II_1-II_7